Quick Answer
CYTOKINETICS INC reported Stockholders Equity of -$659.62 million for fiscal year 2025.
CYTOKINETICS INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$659.62M | -387.3% |
| 2024 | -$135.37M | +65.0% |
| 2023 | -$386.32M | -258.0% |
| 2022 | -$107.90M | -144.2% |
| 2021 | $243.86M | +115.1% |
| 2020 | $113.38M | +1136.7% |
| 2019 | -$10.94M | -142.2% |
| 2018 | $25.93M | -76.4% |
| 2017 | $109.84M | +16.4% |
| 2016 | $94.36M | +37.6% |
| 2015 | $68.59M | -25.5% |
| 2014 | $92.06M | +69.1% |
| 2013 | $54.44M | -22.3% |
| 2012 | $70.08M | +45.5% |
| 2011 | $48.18M | -31.7% |
| 2010 | $70.52M | -30.5% |
| 2009 | $101.43M | +103.8% |
| 2008 | $49.77M | -50.2% |
| 2007 | $99.92M | -6.0% |
| 2006 | $106.31M | +44.5% |
| 2005 | $73.56M | -31.6% |
| 2004 | $107.56M | +216.9% |
| 2003 | -$92.03M | -51.9% |
| 2002 | -$60.59M | -62.2% |
| 2001 | -$37.35M | -71.2% |
| 2000 | -$21.82M | -139.2% |
| 1999 | -$9.12M | -354.9% |
| 1998 | -$2.00M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$521.12M | -3646.1% | -41.3% |
| June 30, 2025 | -$368.72M | -439.7% | -38.4% |
| March 31, 2025 | -$266.41M | +32.8% | -96.8% |
| December 31, 2024 | -$135.37M | +65.0% | -873.1% |
| September 30, 2024 | -$13.91M | +96.8% | -112.8% |
| June 30, 2024 | $108.55M | +132.6% | +127.4% |
| March 31, 2024 | -$396.16M | -73.0% | -2.5% |
| December 31, 2023 | -$386.32M | -258.0% | +12.0% |
- CYTOKINETICS INC showed a decrease of -387.3% in Stockholders Equity compared to the prior fiscal year.
- Over the 1998–2025 period, CYTOKINETICS INC’s stockholders equity has declined by 32799.0% (from -$2.00 million to -$659.62 million).
- The most recent figure is from CYTOKINETICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: